Recent analyses also highlight that some keratin forms (KRT33B, KRT75) can be used as prognostic biomarkers for early detection of low-grade gliomas, and others (KRT75) can be used to reveal transformation tumors with higher probability to switch from low-grade gliomas to GB [62]. The gene discussed is KRT75; the disease is central nervous system cancer.